467 related articles for article (PubMed ID: 26744291)
41. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
42. Metastatic prostate cancer presenting as tumour-induced osteomalacia.
Layman AAK; Joshi S; Shah S
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31315844
[TBL] [Abstract][Full Text] [Related]
43. [Tumor localization and treatment of tumor-induced osteomalacia].
Beil FT; Stürznickel J; Rolvien T; Amling M; Oheim R
Z Rheumatol; 2022 Apr; 81(3):182-188. PubMed ID: 35103802
[TBL] [Abstract][Full Text] [Related]
44. Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.
Mishra D; Kaur H; Bhalla AS; Manchanda S; Sasikumar J; Agarwal B; Roychoudhury A
Head Neck Pathol; 2021 Sep; 15(3):975-988. PubMed ID: 33394371
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report.
Pedrazzoli M; Colletti G; Ferrari M; Rossetti G; Moneghini L; Autelitano L
Int J Oral Maxillofac Surg; 2010 Oct; 39(10):1027-32. PubMed ID: 20483563
[TBL] [Abstract][Full Text] [Related]
46. Tumour-induced osteomalacia (TIO).
Molendowska A; Jakubowska J; Jędrzejuk D; Szymczak J
Endokrynol Pol; 2022; 73(5):903-904. PubMed ID: 36621920
[TBL] [Abstract][Full Text] [Related]
47. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
Seemann L; Padala SA; Mohammed A; Belayneh N
J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
[TBL] [Abstract][Full Text] [Related]
48. Ovarian cancer-related hypophosphatemic osteomalacia--a case report.
Lin HA; Shih SR; Tseng YT; Chen CH; Chiu WY; Hsu CY; Tsai KS
J Clin Endocrinol Metab; 2014 Dec; 99(12):4403-7. PubMed ID: 25181387
[TBL] [Abstract][Full Text] [Related]
49. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
50. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
[TBL] [Abstract][Full Text] [Related]
51. The Right Leg that Troubled the Left Leg.
B S; V A
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017
[TBL] [Abstract][Full Text] [Related]
52. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
[No Abstract] [Full Text] [Related]
53. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S
J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653
[TBL] [Abstract][Full Text] [Related]
54. Oncogenic osteomalacia induced by a sinonasal tumour: case report and review.
Kabtouri H; Karmali R; Spinato L; Khamaktchian M; Bisschop P
B-ENT; 2014; 10(2):149-55. PubMed ID: 25090814
[TBL] [Abstract][Full Text] [Related]
55. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
[TBL] [Abstract][Full Text] [Related]
56. A Phosphaturic Mesenchymal Tumor Presenting as Reversible Metabolic Myopathy.
Abdulla M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):666-670. PubMed ID: 38725216
[TBL] [Abstract][Full Text] [Related]
57. [Tumor-induced hypophosphatemic osteomalacia].
Ito N; Fukukmoto S
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
[No Abstract] [Full Text] [Related]
58. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
59. Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome.
Colangelo L; Sonato C; Cipriani C; Pepe J; Farinacci G; Palmisano B; Occhiuto M; Riminucci M; Corsi A; Minisola S
Arch Osteoporos; 2023 Jul; 18(1):94. PubMed ID: 37436671
[TBL] [Abstract][Full Text] [Related]
60. A case of hyperparathyroidism secondary to tumor-induced osteomalacia.
Yang Y; Jin P; Zhang S; Chen K; He H; Mo Z; Yuan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1937-1944. PubMed ID: 38448388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
